Q2 FY2026 EarningsQ2 FY26 results significantly missed consensus across all key financial metrics, with revenue of $321K trailing the $4.96M expected by 93.5%. The company reported a gross loss of $70K against an expected positive gross margin of 43%, driven by higher outsourcing costs and resource allocation in the Go IPO segment. Despite strategic divestitures of Sigmaways and HeartCore Luvina, the widening net loss of $2.0M and restricted cash position suggest substantial execution risks in the transition to a pure-play capital markets and financial services model.